Literature DB >> 19550304

Regional anesthesia and obesity.

Jerry Ingrande1, Jay B Brodsky, Hendrikus Jm Lemmens.   

Abstract

PURPOSE OF REVIEW: Worldwide, the number of overweight and obese patients has increased dramatically. As a result, anesthesiologists routinely encounter obese patients daily in their clinical practice. The use of regional anesthesia is becoming increasingly popular for these patients. When appropriate, a regional anesthetic offers advantages and should be considered in the anesthetic management plan of obese patients. The following is a review of regional anesthesia in obesity, with special consideration of the unique challenges presented to the anesthesiologist by the obese patient. RECENT
FINDINGS: Recent studies report difficulty in achieving peripheral and neuraxial blockade in obese patients. For example, there is an increased incidence of failed blocks in obese patients compared with similar, normal weight patients. Despite difficulties, regional anesthesia can be used successfully in obese patients, even in the ambulatory surgery setting.
SUMMARY: Successful peripheral and neuraxial blockade in obese patients requires an anesthesiologist experienced in regional techniques, and one with the knowledge of the physiologic and pharmacologic differences that are unique to the obese patient.

Entities:  

Mesh:

Year:  2009        PMID: 19550304     DOI: 10.1097/ACO.0b013e32832eb7bd

Source DB:  PubMed          Journal:  Curr Opin Anaesthesiol        ISSN: 0952-7907            Impact factor:   2.706


  9 in total

1.  Ultrasound-guided peripheral regional anaesthesia: a feasibility study in obese versus normal-weight women.

Authors:  P Marhofer; B Pilz-Lubsczyk; P-A Lönnqvist; E Fleischmann
Journal:  Int J Obes (Lond)       Date:  2013-06-25       Impact factor: 5.095

2.  Comparison of general versus isolated regional anesthesia in total shoulder arthroplasty: A retrospective propensity-matched cohort analysis.

Authors:  David Y Ding; Siddharth A Mahure; Brent Mollon; Steven D Shamah; Joseph D Zuckerman; Young W Kwon
Journal:  J Orthop       Date:  2017-07-21

3.  Severe and morbid obesity (BMI ≥ 35 kg/m(2)) does not increase surgical time and length of hospital stay in total knee arthroplasty surgery.

Authors:  Luis M Lozano; Monserrat Tió; J Rios; Gerard Sanchez-Etayo; Dragos Popescu; Sergi Sastre; Misericordia Basora
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-04-26       Impact factor: 4.342

Review 4.  Anesthetic challenges in the obese patient.

Authors:  Rudin Domi; Haki Laho
Journal:  J Anesth       Date:  2012-05-06       Impact factor: 2.078

5.  Ultrasound-guided multiple peripheral nerve blocks in a superobese patient.

Authors:  Alper Kilicaslan; Ahmet Topal; Atilla Erol; Hale Borazan; Onur Bilge; Seref Otelcioglu
Journal:  Case Rep Anesthesiol       Date:  2014-01-22

6.  Paramedian epidural with midline spinal in the same intervertebral space: An alternative technique for combined spinal and epidural anaesthesia.

Authors:  Deepti Saigal; Rama Wason
Journal:  Indian J Anaesth       Date:  2013-07

7.  Peri-operative management of the obese surgical patient 2015: Association of Anaesthetists of Great Britain and Ireland Society for Obesity and Bariatric Anaesthesia.

Authors:  C E Nightingale; M P Margarson; E Shearer; J W Redman; D N Lucas; J M Cousins; W T A Fox; N J Kennedy; P J Venn; M Skues; D Gabbott; U Misra; J J Pandit; M T Popat; R Griffiths
Journal:  Anaesthesia       Date:  2015-05-07       Impact factor: 6.955

8.  Tube or not tube in COVID-19 positive patients: that is the question.

Authors:  Pierfrancesco Fusco; Laura Pizzorno; Valentina Arcangeli; Franco Marinangeli
Journal:  Korean J Anesthesiol       Date:  2021-05-03

9.  The effects of shoulder arthroscopy on ultrasound image quality of the interscalene brachial plexus: a pre-procedure vs post-procedure comparative study.

Authors:  Jason K Panchamia; Ram Jagannathan; Bridget P Pulos; Adam W Amundson; Joaquin Sanchez-Sotelo; David P Martin; Hugh M Smith
Journal:  BMC Anesthesiol       Date:  2021-07-09       Impact factor: 2.217

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.